The DOI matches its Crossref record; 88 of the 88 references it cites were found in a registry or an index.
Parkin gene inactivation alters behaviour and dopamine neurotransmission in the mouse
Abstract
Mutations of the parkin gene are the most frequent cause of early onset autosomal recessive parkinsonism (EO-AR). Here we show that inactivation of the parkin gene in mice results in motor and cognitive deficits, inhibition of amphetamine-induced dopamine release and inhibition of glutamate neurotransmission. The levels of dopamine are increased in the limbic brain areas of parkin mutant mice and there is a shift towards increased metabolism of dopamine by MAO. Although there was no evidence for a reduction of nigrostriatal dopamine neurons in the parkin mutant mice, the level of dopamine transporter protein was reduced in these animals, suggesting a decreased density of dopamine terminals, or adaptative changes in the nigrostriatal dopamine system. GSH levels were increased in the striatum and fetal mesencephalic neurons from parkin mutant mice, suggesting that a compensatory mechanism may protect dopamine neurons from neuronal death. These parkin mutant mice provide a valuable tool to better understand the preclinical deficits observed in patients with PD and to characterize the mechanisms leading to the degeneration of dopamine neurons that could provide new strategies for neuroprotection.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Molecular Cloning: A Laboratory Manual
Sambrook, J., Fritsch, E., & Maniatis, T. (1989) · UCLA - Biblioteca de Ciencias de la Salud · Cited by 133,589
Mutation in the α-Synuclein Gene Identified in Families with Parkinson's Disease
Polymeropoulos, M. H., Lavedan, C., Leroy, E., Ide, S. E., Dehejia, A., Dutra, A., Pike, B., Root, H., Rubenstein, J., Boyer, R., et al. (1997) · Science · doi:10.1126/science.276.5321.2045 · Cited by 8,240
Ashburner, M. (1989) · Cold Spring Harbor Laboratory eBooks · Cited by 6,756
Tietze, F. (1969) · Analytical Biochemistry · doi:10.1016/0003-2697(69)90064-5 · Cited by 6,047
Mutations in the parkin gene cause autosomal recessive juvenile parkinsonism
Kitada, T., Asakawa, S., Hattori, N., Matsumine, H., Yamamura, Y., Minoshima, S., Yokochi, M., Mizuno, Y., & Shimizu, N. (1998) · Nature · doi:10.1038/33416 · Cited by 5,227
Short-Term Synaptic Plasticity
Zucker, R. S., & Regehr, W. G. (2002) · Annual Review of Physiology · doi:10.1146/annurev.physiol.64.092501.114547 · Cited by 5,068
Di Chiara, G., & Imperato, A. (1988) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.85.14.5274 · Cited by 4,733
Griffith, O. W. (1980) · Analytical Biochemistry · doi:10.1016/0003-2697(80)90139-6 · Cited by 4,602
Hyperlocomotion and indifference to cocaine and amphetamine in mice lacking the dopamine transporter
Giros, B., Jaber, M., Jones, S. R., Wightman, R. M., & Caron, M. G. (1996) · Nature · doi:10.1038/379606a0 · Cited by 2,476
Mice Lacking α-Synuclein Display Functional Deficits in the Nigrostriatal Dopamine System
Abeliovich, A., Schmitz, Y., Fariñas, I., Choi-Lundberg, D., Ho, W.-H., Castillo, P. E., Shinsky, N., Verdugo, J. M. G., Armanini, M., Ryan, A., et al. (2000) · Neuron · doi:10.1016/s0896-6273(00)80886-7 · Cited by 1,722
Neuropathology of Parkinsonʼs Disease
Forno, L. S. (1996) · Journal of Neuropathology and Experimental Neurology · doi:10.1097/00005072-199603000-00001 · Cited by 1,465
Short-Term Synaptic Plasticity
Zucker, R. S. (1989) · Annual Review of Neuroscience · doi:10.1146/annurev.ne.12.030189.000305 · Cited by 1,447
Association between Early-Onset Parkinson's Disease and Mutations in the Parkin Gene
Lücking, C. B., Dürr, A., Bonifati, V., Vaughan, J., De Michele, G., Gasser, T., Harhangi, B. S., Meco, G., Denèfle, P., Wood, N. W., et al. (2000) · New England Journal of Medicine · doi:10.1056/nejm200005253422103 · Cited by 1,433
Transition metals, ferritin, glutathione, and ascorbic acid in parkinsonian brains
Riederer, P., Sofic, E., Rausch, W., Schmidt, B., Reynolds, G. P., Jellinger, K., & Youdim, M. B. H. (1989) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.1989.tb09150.x · Cited by 1,383
Neuronal α-Synucleinopathy with Severe Movement Disorder in Mice Expressing A53T Human α-Synuclein
Giasson, B. I., Duda, J. E., Quinn, S. M., Zhang, B., Trojanowski, J. Q., & Lee, V. M.-Y. (2002) · Neuron · doi:10.1016/s0896-6273(02)00682-7 · Cited by 1,266
Mitochondrial pathology and apoptotic muscle degeneration in Drosophila parkin mutants
Greene, J. C., Whitworth, A. J., Kuo, I., Andrews, L. A., Feany, M. B., & Pallanck, L. J. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0737556100 · Cited by 1,203
Depression and Parkinson's disease: a review
(1992) · American Journal of Psychiatry · doi:10.1176/ajp.149.4.443 · Cited by 1,111
Shimura, H., Schlossmacher, M. G., Hattori, N., Frosch, M. P., Trockenbacher, A., Schneider, R., Mizuno, Y., Kosik, K. S., & Selkoe, D. J. (2001) · Science · doi:10.1126/science.1060627 · Cited by 1,053
Imai, Y., Soda, M., Inoue, H., Hattori, N., Mizuno, Y., & Takahashi, R. (2001) · Cell · doi:10.1016/s0092-8674(01)00407-x · Cited by 1,050
Zhang, Y., Gao, J., Chung, K. K. K., Huang, H., Dawson, V. L., & Dawson, T. M. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.240347797 · Cited by 982
Cabin, D. E., Shimazu, K., Murphy, D., Cole, N. B., Gottschalk, W., McIlwain, K. L., Orrison, B., Chen, A., Ellis, C. E., Paylor, R., et al. (2002) · The Journal of Neuroscience · doi:10.1523/jneurosci.22-20-08797.2002 · Cited by 865
Beal, M. F. (2002) · Free Radical Biology and Medicine · doi:10.1016/s0891-5849(02)00780-3 · Cited by 763 · cited 1×
“This suggests that the pathogenesis of the disease may be related to excessive oxidative stress, lack of free radical scavenging products or abnormalities of mitochondrial energy production (8,9).”
BackgroundChung, K. K. K., Zhang, Y., Lim, K. L., Tanaka, Y., Huang, H., Gao, J., Ross, C. A., Dawson, V. L., & Dawson, T. M. (2001) · Nature Medicine · doi:10.1038/nm1001-1144 · Cited by 750
Sulzer, D., Chen, T., Lau, Y., Kristensen, H., Rayport, S., & Ewing, A. (1995) · The Journal of Neuroscience · doi:10.1523/jneurosci.15-05-04102.1995 · Cited by 688
Hunot, S., Brugg, B., Ricard, D., Michel, P. P., Muriel, M.-P., Ruberg, M., Faucheux, B. A., Agid, Y., & Hirsch, E. C. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.14.7531 · Cited by 678
Animal models of Parkinson's disease
Betarbet, R., Sherer, T. B., & Greenamyre, J. T. (2002) · BioEssays · doi:10.1002/bies.10067 · Cited by 592
Reduced and oxidized glutathione in the substantia nigra of patients with Parkinson's disease
Sofic, E., Lange, K. W., Jellinger, K., & Riederer, P. (1992) · Neuroscience Letters · doi:10.1016/0304-3940(92)90355-b · Cited by 590
Rudnick, G., & Wall, S. C. (1992) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.89.5.1817 · Cited by 535
Abbas, N., Lucking, C. B., Ricard, S., Durr, A., Bonifati, V., De Michele, G., Bouley, S., Vaughan, J. R., Gasser, T., Marconi, R., et al. (1999) · Human Molecular Genetics · doi:10.1093/hmg/8.4.567 · Cited by 530
Prevalence of Parkinson's disease in Europe : A collaborative study of population-based cohorts
de Rijk, M. C., Launer, L. J., Berger, K., Breteler, M. M. B., Dartigues, J. F., Baldereschi, M., Fratiglioni, L., Lobo, A., Martínez‐Lage, J. M., Trenkwalder, C., et al. (2000) · EUR Research Repository (Erasmus University Rotterdam) · Cited by 514
Gerlach, M., & Riederer, P. (1996) · Journal of Neural Transmission · doi:10.1007/bf01291788 · Cited by 498
Mutations in NR4A2 associated with familial Parkinson disease
Le, W.-D., Xu, P., Jankovic, J., Jiang, H., Appel, S. H., Smith, R. G., & Vassilatis, D. K. (2003) · Nature Genetics · doi:10.1038/ng1066 · Cited by 487
Lewy bodies and parkinsonism in families with parkin mutations
Farrer, M., Chan, P., Chen, R., Tan, L., Lincoln, S., Hernandez, D., Forno, L., Gwinn‐Hardy, K., Petrucelli, L., Hussey, J., et al. (2001) · Annals of Neurology · doi:10.1002/ana.1132 · Cited by 485
(2001) · doi:10.1523/jneurosci.21-24-09549.2001 · Cited by 476
Glutathione, iron and Parkinson’s disease
Bharath, S., Hsu, M., Kaur, D., Rajagopalan, S., & Andersen, J. K. (2002) · Biochemical Pharmacology · doi:10.1016/s0006-2952(02)01174-7 · Cited by 396
Risk tables for parkinsonism and Parkinson’s disease
Elbaz, A., Bower, J. H., Maraganore, D. M., McDonnell, S. K., Peterson, B. J., Ahlskog, J. E., Schaid, D. J., & Rocca, W. A. (2002) · Journal of Clinical Epidemiology · doi:10.1016/s0895-4356(01)00425-5 · Cited by 377
The septin CDCrel-1 binds syntaxin and inhibits exocytosis
Beites, C. L., Xie, H., Bowser, R., & Trimble, W. S. (1999) · Nature Neuroscience · doi:10.1038/8100 · Cited by 377
Pathologic and biochemical studies of juvenile parkinsonism linked to chromosome 6q
Mori, H., Kondo, T., Yokochi, M., Matsumine, H., Nakagawa-Hattori, Y., Miyake, T., Suda, K., & Mizuno, Y. (1998) · Neurology · doi:10.1212/wnl.51.3.890 · Cited by 370
Spatial and non-spatial working memory at different stages of Parkinson's disease
Owen, A. M., Iddon, J. L., Hodges, J. R., Summers, B. A., & Robbins, T. W. (1997) · Neuropsychologia · doi:10.1016/s0028-3932(96)00101-7 · Cited by 355
Effect of Mutant α-Synuclein on Dopamine Homeostasis in a New Human Mesencephalic Cell Line
Lotharius, J., Barg, S., Wiekop, P., Lundberg, C., Raymon, H. K., & Brundin, P. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m205518200 · Cited by 352
Guilt, fear, submission, and empathy in depression
O’Connor, L. E., Berry, J. W., Weiss, J., & Gilbert, P. (2002) · Journal of Affective Disorders · doi:10.1016/s0165-0327(01)00408-6 · Cited by 349 · cited 1×
“Moreover, a high degree of submissive behaviour has been observed in depressed patients (70) and depression is frequently a complicating factor in patients with PD (71).”
BackgroundPaired‐pulse and frequency facilitation in the CA1 region of the in vitro rat hippocampus
Creager, R., Dunwiddie, T., & Lynch, G. (1980) · The Journal of Physiology · doi:10.1113/jphysiol.1980.sp013133 · Cited by 343
Toxicity of 6‐hydroxydopamine and dopamine for dopaminergic neurons in culture
Michel, P. P., & Hefti, F. (1990) · Journal of Neuroscience Research · doi:10.1002/jnr.490260405 · Cited by 338
Effect of ethanol on the hydroxylation of tyrosine and tryptophan in rat brain in vivo
Carlsson, A., & Lindqvist, M. (1973) · Journal of Pharmacy and Pharmacology · doi:10.1111/j.2042-7158.1973.tb09129.x · Cited by 312
How much phenotypic variation can be attributed to parkin genotype?
Lohmann, E., Periquet, M., Bonifati, V., Wood, N. W., De Michele, G., Bonnet, A., Fraix, V., Broussolle, E., Horstink, M. W. I. M., Vidailhet, M., et al. (2003) · Annals of Neurology · doi:10.1002/ana.10613 · Cited by 301
Parkin mutations are frequent in patients with isolated early‐onset parkinsonism
Periquet, M., Latouche, M., Lohmann, E., Rawal, N., De Michele, G., Ricard, S., Teive, H., Fraix, V., Vidailhet, M., Nicholl, D., et al. (2003) · Brain · doi:10.1093/brain/awg136 · Cited by 292
Sulzer, D., Maidment, N. T., & Rayport, S. (1993) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.1993.tb03181.x · Cited by 291
Handbook of Parkinson's Disease
(2013) · CRC Press eBooks · doi:10.1201/b14361 · Cited by 272
Familial juvenile Parkinsonism.
Carlier, G., & Jm, D. (1979) · PubMed · Cited by 261
Clinical and pathologic abnormalities in a family with parkinsonism and parkin gene mutations
van de Warrenburg, B. P. C., Lammens, M., Lücking, C. B., Denèfle, P., Wesseling, P., Booij, J., Praamstra, P., Quinn, N., Brice, A., & Horstink, M. W. I. M. (2001) · Neurology · doi:10.1212/wnl.56.4.555 · Cited by 255
Mitochondria in the etiology and pathogenesis of parkinson's disease
Schapira, A. H. V., Gu, M., Taanman, J. ‐., Tabrizi, S. J., Seaton, T., Cleeter, M., & Cooper, J. M. (1998) · Annals of Neurology · doi:10.1002/ana.410440714 · Cited by 238
Murer, M. G., Dziewczapolski, G., Menalled, L. B., García, M. C., Agid, Y., Gershanik, O., & Raisman‐Vozari, R. (1998) · Annals of Neurology · doi:10.1002/ana.410430504 · Cited by 232
Parkin deletions in a family with adult-onset, tremor-dominant parkinsonism: Expanding the phenotype
Klein, C., Pramstaller, P. P., Kis, B., Page, C. E., Kann, M., Leung, J., Woodward, H., Castellan, C. C., Scherer, M., Vieregge, P., et al. (2000) · Annals of Neurology · doi:10.1002/1531-8249(200007)48:1<65::aid-ana10>3.0.co;2-l · Cited by 228
Immunochemical Analysis of Vesicular Monoamine Transporter (VMAT2) Protein in Parkinson's Disease
Miller, G. W., Erickson, J. D., Perez, J. T., Penland, S. N., Mash, D. C., Rye, D. B., & Levey, A. I. (1999) · Experimental Neurology · doi:10.1006/exnr.1998.7008 · Cited by 215
Hayashi, S., Wakabayashi, K., Ishikawa, A., Nagai, H., Saito, M., Maruyama, M., Takahashi, T., Ozawa, T., Tsuji, S., & Takahashi, H. (2000) · Movement Disorders · doi:10.1002/1531-8257(200009)15:5<884::aid-mds1019>3.0.co;2-8 · Cited by 212
Moll, G. H., Mehnert, C., Wicker, M., Bock, N., Rothenberger, A., Rüther, E., & Huether, G. (2000) · Developmental Brain Research · doi:10.1016/s0165-3806(99)00182-0 · Cited by 204
Complex relationship between Parkin mutations and Parkinson disease
West, A., Periquet, M., Lincoln, S., Lücking, C. B., Nicholl, D., Bonifati, V., Rawal, N., Gasser, T., Lohmann, E., Deleuze, J., et al. (2002) · American Journal of Medical Genetics · doi:10.1002/ajmg.10525 · Cited by 203
Depression and Parkinson?s disease
Lemke, M., Fuchs, G., Gemende, I., Herting, B., Oehlwein, C., Reichmann, H., Rieke, J., & Volkmann, J. (2004) · Journal of Neurology · doi:10.1007/s00415-004-1606-6 · Cited by 200
Dunwiddie, T. V., & Haas, H. L. (1985) · The Journal of Physiology · doi:10.1113/jphysiol.1985.sp015907 · Cited by 192
Noradrenaline provides long‐term protection to dopaminergic neurons by reducing oxidative stress
Troadec, J., Marien, M. R., Darios, F. D., Hartmann, A., Ruberg, M., Colpaert, F. C., & Michel, P. P. (2001) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2001.00556.x · Cited by 174
Hyun, D.-H., Lee, M., Hattori, N., Kubo, S.-I., Mizuno, Y., Halliwell, B., & Jenner, P. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m200666200 · Cited by 172
α-Synuclein and the Lewy body disorders
Dickson, D. W. (2001) · Current Opinion in Neurology · doi:10.1097/00019052-200108000-00001 · Cited by 164
A Molecular Glimpse of Vesicular Monoamine Transporters
Schuldiner, S. (1994) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.1994.62062067.x · Cited by 150
Toxic effects of L-DOPA on mesencephalic cell cultures: protection with antioxidants
Pardo, B., Mena, M. A., Casarejos, M. J., Paíno, C. L., & de Yébenes, J. G. (1995) · Brain Research · doi:10.1016/0006-8993(95)00341-m · Cited by 144
The personality associated with Parkinson’s disease
Menza, M. A. (2000) · Current Psychiatry Reports · doi:10.1007/s11920-000-0027-1 · Cited by 140
Neurotoxicity of levodopa on catecholamine‐rich neurons
Mena, M. A., Pardo, B., Casarejos, M. J., Fahn, S., & de Yébenes, J. G. (1992) · Movement Disorders · doi:10.1002/mds.870070105 · Cited by 138
Parkin is associated with cellular vesicles
Kubo, S., Kitami, T., Noda, S., Shimura, H., Uchiyama, Y., Asakawa, S., Minoshima, S., Shimizu, N., Mizuno, Y., & Hattori, N. (2001) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2001.00364.x · Cited by 137
Parkinsons Disease - Redox Mechanisms
Adams, J. D., Jr., Chang, M., & Klaidman, L. K. (2001) · Current Medicinal Chemistry · doi:10.2174/0929867013372995 · Cited by 136
Boulay, D., Depoortère, R., Perrault, G., Borrelli, E., & Sanger, D. J. (1999) · Neuropharmacology · doi:10.1016/s0028-3908(99)00064-7 · Cited by 107
Dı́az-Torga, G., Feierstein, C., Libertun, C., Gelman, D. M., Kelly, M. A., Low, M. J., Rubinstein, M., & Becú‐Villalobos, D. (2002) · Endocrinology · doi:10.1210/endo.143.4.8750 · Cited by 101
Neuroprotective Strategies in Parkinson's Disease Using the Models of 6‐Hydroxydopamine and MPTPa
Grünblatt, E., Mandel, S. A., & Youdim, M. B. H. (2000) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2000.tb06192.x · Cited by 98
Mena, M. A., Casarejos, M. J., Carazo, A., Paíno, C. L., & de Yébenes, J. G. (1997) · Journal of Neural Transmission · doi:10.1007/bf01277654 · Cited by 97
Glia conditioned medium protects fetal rat midbrain neurones in culture from L-DOPA toxicity
Mena, M. A., Casarejos, M. J., Carazo, A., Paíno, C. L., & de Yébenes, J. G. (1996) · Neuroreport · doi:10.1097/00001756-199601310-00016 · Cited by 92
Neurotransmitters in Temperature Control
Lipton, J. M., & Clark, W. G. (1986) · Annual Review of Physiology · doi:10.1146/annurev.ph.48.030186.003145 · Cited by 92
Troadec, J., Marien, M. R., Mourlevat, S., Debeir, T., Ruberg, M., Colpaert, F. C., & Michel, P. P. (2002) · Molecular Pharmacology · doi:10.1124/mol.62.5.1043 · Cited by 86
Canals, S., Casarejos, M. J., de Bernardo, S., Rodríguez‐Martín, E., & Mena, M. A. (2001) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2001.00635.x · Cited by 67
Patel, J. C., Mooslehner, K. A., Chan, P. M., Emson, P. C., & Stamford, J. A. (2003) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2003.01732.x · Cited by 66
Steele‐Richardson‐Olszewski syndrome in a patient with a single C212Y mutation in the parkin protein
Morales, B., Martínez, A., Gonzalo, I., Vidal, L., Ros, R., Gómez‐Tortosa, E., Rábano, A., Ampuero, I., Sánchez, M. P., Hoenicka, J., et al. (2002) · Movement Disorders · doi:10.1002/mds.10264 · Cited by 61
Improved Detection of Substantia Nigra Pathology in Alzheimer's Disease
Schneider, J. A., Bienias, J. L., Gilley, D. W., Kvarnberg, D. E., Mufson, E. J., & Bennett, D. A. A. (2002) · Journal of Histochemistry & Cytochemistry · doi:10.1177/002215540205000111 · Cited by 57
Mena, M. A., Casarejos, M. J., Bonnin, A., Ramos, J. A., & de Yébenes, J. G. (1995) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.1995.65062612.x · Cited by 55
Molecular Findings in Familial Parkinson Disease in Spain
Hoenicka, J., Vidal, L., Morales, B., Ampuero, I., Jiménez‐Jiménez, F. J., Berciano, J., del Ser, T., Jiménez, A., Ruiz, P., & de Yébenes, J. G. (2002) · Archives of Neurology · doi:10.1001/archneur.59.6.966 · Cited by 48
Hirsch, M. D., & Helke, C. J. (1988) · Neuroscience · doi:10.1016/0306-4522(88)90264-3 · Cited by 43
Personality, depression, and premorbid lifestyle in twin pairs discordant for Parkinson's disease
Heberlein, I., Ludin, H. P., Scholz, J., & Vieregge, P. (1998) · Journal of Neurology Neurosurgery & Psychiatry · doi:10.1136/jnnp.64.2.262 · Cited by 41
Louis, E. D., Levy, G., Côte, L. J., Mejia, H., Fahn, S., & Marder, K. (2002) · Movement Disorders · doi:10.1002/mds.10119 · Cited by 41
A Synergistic Neurotrophic Response to l-Dihydroxyphenylalanine and Nerve Growth Factor
Mena, M. A., Davila, V., Bogaluvsky, J., & Sulzer, D. (1998) · Molecular Pharmacology · doi:10.1016/s0026-895x(24)13069-6 · Cited by 41
Jaffard, R., Dubois, M., & Galey, D. (1981) · Behavioural Processes · doi:10.1016/0376-6357(81)90012-7 · Cited by 25
Rodríguez‐Martín, E., Canals, S., Casarejos, M. J., de Bernardo, S., Handler, A., & Mena, M. A. (2001) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2001.00440.x · Cited by 22
Mena, M. A., Casarejos, M. J., & de Yébenes, J. G. (1999) · Journal of Neural Transmission · doi:10.1007/s007020050227 · Cited by 19
Cited by
The Roles of PINK1, Parkin, and Mitochondrial Fidelity in Parkinson’s Disease
Pickrell, A. M., & Youle, R. J. (2015) · Neuron · doi:10.1016/j.neuron.2014.12.007 · Cited by 2,310
MOLECULAR PATHOPHYSIOLOGY OF PARKINSON'S DISEASE
Moore, D. J., West, A. B., Dawson, V. L., & Dawson, T. M. (2005) · Annual Review of Neuroscience · doi:10.1146/annurev.neuro.28.061604.135718 · Cited by 1,280
Autophagy and Neurodegeneration: Pathogenic Mechanisms and Therapeutic Opportunities
Menzies, F. M., Fleming, A., Caricasole, A., Bento, C. F., Andrews, S. P., Ashkenazi, A., Füllgrabe, J., Jackson, A., Jimenez Sanchez, M., Karabiyik, C., et al. (2017) · Neuron · doi:10.1016/j.neuron.2017.01.022 · Cited by 1,134
Mitochondrial Dysfunction and Oxidative Damage in parkin-deficient Mice
Palacino, J. J., Sagi, D., Goldberg, M. S., Krauss, S., Motz, C., Wacker, M., Klose, J., & Shen, J. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m401135200 · Cited by 995
Expanding insights of mitochondrial dysfunction in Parkinson's disease
Abou-Sleiman, P. M., Muqit, M. M. K., & Wood, N. W. (2006) · Nature Reviews Neuroscience · doi:10.1038/nrn1868 · Cited by 869
Metadata
- Authors
- Itier, J.-M.
- Venue
- Human Molecular Genetics
- Publisher
- Oxford University Press (OUP)
- Published
- 2003-07-15
- Volume
- 12
- Issue
- 18
- Pages
- 2277-2291
- ISSN
- 0964-6906 (ISSN-L)
- 1460-2083
- OpenAlex
- W2158259597
- Cited by
- 508
- References
- 88
- FWCI
- 21.33
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.